New research suggests that a recently developed human papillomavirus (HPV) vaccine can potentially prevent 80 percent of cervical cancers if it is administered before the child is 11 or 12 years old. HPV is a common sexually transmitted infection that can spread from one partner to another through vaginal, anal, or oral sex. And an estimated three-quarters of sexually active women are believed to have caught HPV at some point in their life. In the study, it was discovered that the new version of the 9-Valent vaccine — which guards against seven cancer-causing HPV strains — can potentially protect against 19,000 other cancers, including anal, oral, and penile. This advanced vaccine is also said to increase the protection from HPV-related cancers, including those of the vulva, from 71 to 92 percent; vagina, from 73 percent to 98 percent; the penis, 76 percent to 90 percent; and the anus, 87 percent to 96 percent. “This...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




